These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 3038420)
21. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition. Clappison BH; Anderson WP; Johnston CI Kidney Int; 1981 Nov; 20(5):615-20. PubMed ID: 6283229 [TBL] [Abstract][Full Text] [Related]
22. Effect of aprotinin-induced kallikrein inhibition on the cardiovascular and renal action of captopril in diuretic-treated dogs. Vemulapalli S; Chiu PJ Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):109-23. PubMed ID: 6191727 [TBL] [Abstract][Full Text] [Related]
23. Effects of captopril on blood pressure and renin-angiotensin-aldosterone system in hypertensive subjects after inhibition of renal vasodilative system. Santucci A; Aguglia F; De Mattia G; Cammarella I; Giordano M; Gnecchi M; Trinchieri F; Ficara C Int J Clin Pharmacol Res; 1984; 4(1):41-5. PubMed ID: 6381343 [TBL] [Abstract][Full Text] [Related]
24. Use of captopril to estimate renin-angiotensin-aldosterone activity in the pathophysiology of chronic heart failure. Cody RJ; Laragh JH Am Heart J; 1982 Nov; 104(5 Pt 2):1184-9. PubMed ID: 6291364 [TBL] [Abstract][Full Text] [Related]
25. [Therapy with ACE inhibitors in chronic heart failure and limited kidney function]. Osterziel KJ; Nagel F; Dietz R Z Kardiol; 1994; 83 Suppl 4():81-7. PubMed ID: 7856286 [TBL] [Abstract][Full Text] [Related]
26. Effects of captopril on forearm oxygen consumption during dynamic handgrip exercise in patients with congestive heart failure. Imaizumi T; Takeshita A; Nakamura N; Sakai K; Hirooka Y; Suzuki S; Yoshida M; Nakamura M Jpn Heart J; 1990 Nov; 31(6):817-28. PubMed ID: 2084278 [TBL] [Abstract][Full Text] [Related]
27. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril. Hollenberg NK Am J Med; 1984 May; 76(5B):22-8. PubMed ID: 6328983 [TBL] [Abstract][Full Text] [Related]
28. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure. Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786 [TBL] [Abstract][Full Text] [Related]
29. Effect of the serine protease inhibitor, aprotinin, on systemic haemodynamics and renal function in patients with hepatic cirrhosis and ascites. MacGilchrist A; Craig KJ; Hayes PC; Cumming AD Clin Sci (Lond); 1994 Sep; 87(3):329-35. PubMed ID: 7525142 [TBL] [Abstract][Full Text] [Related]
30. [The changes in renin-angiotensin-aldosterone system in acute myocardial infarction and the effects of converting enzyme inhibitor-captopril]. Jiang M Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):342-4, 396. PubMed ID: 1668233 [TBL] [Abstract][Full Text] [Related]
31. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. Dzau VJ; Colucci WS; Williams GH; Curfman G; Meggs L; Hollenberg NK N Engl J Med; 1980 Jun; 302(25):1373-9. PubMed ID: 6246425 [TBL] [Abstract][Full Text] [Related]
32. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril. Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346 [TBL] [Abstract][Full Text] [Related]
33. Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure. Motwani JG; Fenwick MK; Morton JJ; Struthers AD Circulation; 1992 Aug; 86(2):439-45. PubMed ID: 1638713 [TBL] [Abstract][Full Text] [Related]
34. Differential actions of vasopeptidase inhibition versus angiotensin-converting enzyme inhibition on diuretic therapy in experimental congestive heart failure. Cataliotti A; Boerrigter G; Chen HH; Jougasaki M; Costello LC; Tsuruda T; Lee SC; Malatino LS; Burnett JC Circulation; 2002 Feb; 105(5):639-44. PubMed ID: 11827932 [TBL] [Abstract][Full Text] [Related]
35. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy. Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458 [TBL] [Abstract][Full Text] [Related]
37. The effect of aprotinin (a serine protease inhibitor) on renal function and renin release. Seto S; Kher V; Scicli AG; Beierwaltes WH; Carretero OA Hypertension; 1983; 5(6):893-9. PubMed ID: 6197374 [TBL] [Abstract][Full Text] [Related]
38. Effects of captopril and enalapril on renal function in elderly patients with chronic heart failure. Haffner CA; Kendall MJ; Struthers AD; Bridges A; Stott DJ Postgrad Med J; 1995 May; 71(835):287-92. PubMed ID: 7596934 [TBL] [Abstract][Full Text] [Related]
39. Effects of renin inhibition compared to angiotensin converting enzyme inhibition in conscious dogs with pacing-induced heart failure. Shannon RP; Friedrich S; Mathier M; Knight DR Cardiovasc Res; 1997 Jun; 34(3):464-72. PubMed ID: 9231029 [TBL] [Abstract][Full Text] [Related]
40. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study. MacFadyen RJ; Lees KR; Reid JL Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]